Ujvira 160 mg Injection is an advanced targeted cancer treatment containing Trastuzumab Emtansine, a medicine from the Antibody-Drug Conjugates (ADC) category. It works by combining a monoclonal antibody with chemotherapy, allowing the drug to directly target cancer cells while minimizing harm to healthy tissues. This precision-based approach helps improve treatment effectiveness and reduces the impact of traditional chemotherapy side effects.

This injection is mainly prescribed for HER2-positive metastatic breast cancer, especially in cases where the disease has returned or spread and complete cure may not be possible. Ujvira binds specifically to HER2 receptors on cancer cells and delivers chemotherapy inside them, blocking their growth and survival. It is administered intravenously under medical supervision, with dosage tailored to each patient. Common side effects may include nausea, mouth sores, rashes, numbness in the hands or feet, joint pain, hair loss, and urinary infections, and patients should consult their doctor if any symptoms worsen.

Ujvira 160 mg Injection works through an advanced targeted therapy approach for HER2-positive breast cancer by using trastuzumab to accurately identify and bind to HER2 receptors on cancer cells, ensuring precise targeting. Once attached, it delivers the chemotherapy agent emtansine directly inside the cancer cells, helping to stop their growth and destroy them from within. This focused drug delivery minimizes damage to healthy surrounding tissues and offers improved treatment effectiveness with fewer side effects compared to conventional chemotherapy, making Ujvira a safer and more efficient option for eligible patients.

Side Effects of Ujvira 160 mg Injection

Like all medications, Ujvira 160 mg Injection may cause side effects. However, not everyone will experience them.

Serious Side Effects (Seek immediate medical attention):

• Severe liver problems or liver failure
• Serious allergic reactions (rash, swelling, breathing trouble)
• Heart problems (such as reduced heart function or heart failure)
• Signs of infection (fever, chills, sore throat)
• Serious lung problems, including difficulty breathing or interstitial lung disease
• Vision changes or eye irritation.

Note: Always consult your doctor if you experience any unusual symptoms or if common side effects become severe.

Common Side Effects (Usually mild and temporary):

These are usually mild to moderate and may improve as your body adjusts to the treatment:

• Nausea or vomiting
• Fatigue or tiredness
• Mouth sores or ulcers
• Diarrhea or constipation
• Headache
• Muscle or joint pain
• Hair thinning or hair loss
• Skin rash or itching
• Insomnia (difficulty sleeping)
• Tingling or numbness in hands and feet (peripheral neuropathy)
• Low red blood cell count (anemia)
• Increased liver enzymes (seen in blood tests)

Ujvira 160 mg Injection is given by a healthcare professional through a drip in a hospital or clinic. The dose is based on your body weight, health condition, and how well you respond to treatment, and it is usually given once every three weeks. Your doctor may adjust or delay the dose if side effects occur, so it’s important to follow the treatment schedule exactly as advised.

This medicine is not safe during breastfeeding as it may harm the baby. Avoid breastfeeding during treatment and for at least 7 months after the last dose.

It is best to avoid or limit alcohol while receiving Ujvira 160 mg Injection, as alcohol can increase side effects like liver problems, tiredness, or nausea. Always consult your doctor before drinking alcohol during treatment.

Ujvira 160 mg Injection may sometimes affect the lungs, causing breathing problems like cough, shortness of breath, or chest discomfort. If you notice any new or worsening breathing issues, inform your doctor right away. Regular check-ups and early reporting of symptoms can help prevent serious lung complications during treatment.

Ujvira 160 mg Injection may cause side effects like tiredness, dizziness, or vision changes. If you feel unwell or experience these symptoms, avoid driving or operating heavy machines until you feel better. Always check with your doctor before resuming such activities.

Ujvira 160 mg Injection is not safe to use during pregnancy, as it may harm the unborn baby. Women should use effective birth control during treatment and for a few months after the last dose. If you are pregnant, planning to conceive, or become pregnant while on this medicine, inform your doctor immediately.

Store in a refrigerator (2 - 8°C)

Do not freeze

Keep out of reach of children and pets

Ensure that Ujvira 160mg Injection is given exactly as advised by your oncologist to get the best treatment benefit.

Routine monitoring during treatment helps your doctor assess how well the medicine is working and manage any side effects.

Inform your healthcare provider if you notice fatigue, breathlessness, or swelling during treatment.

Staying hydrated, eating well, and getting enough rest can help your body respond better to cancer therapy.

Ujvira is indicated for the treatment of HER2-positive metastatic or unresectable breast cancer in patients previously treated with trastuzumab and taxane-based chemotherapy.

It is an antibody-drug conjugate that targets HER2-positive cancer cells and delivers chemotherapy directly inside them, limiting damage to healthy tissue.

Ujvira 160mg is given as an intravenous infusion under medical supervision, typically once every 3 weeks.

Regular monitoring of heart function, liver enzymes, and blood counts is required throughout therapy.

No. Ujvira 160mg can cause fetal harm. Effective contraception is required during treatment and for 7 months after the last dose. Breastfeeding should be avoided.

Common effects include fatigue, nausea, thrombocytopenia, peripheral neuropathy, skin rash, and elevated liver enzymes.

Treatment is continued in 3-week cycles until disease progression or unacceptable toxicity, as determined by the physician.

The duration depends on how well your body responds and your doctor’s recommendation. It is typically given in 3-week cycles until disease progression or unacceptable side effects.

If you feel dizzy or tired, it is best to avoid driving or operating machinery until you feel well again.

Hair loss is not commonly reported with Ujvira 160mg treatment. However, side effects can vary from person to person. If you notice unusual hair loss or other concerning changes during treatment, inform your doctor.

Ujvira 160mg Injection is available through Phoenix Pharmex for patients, caregivers, and healthcare providers across India. As a trusted supplier, distributor, and wholesaler, we offer genuine Trastuzumab Emtansine Injection with prescription verification and cold-chain delivery. Ujvira 160mg price varies by pack size and availability — contact us for current pricing.

https://go.drugbank.com/drugs/DB05773

https://pmc.ncbi.nlm.nih.gov/articles/PMC3860880/

https://www.nejm.org/doi/full/10.1056/NEJMoa1814017

The information on the Phoenix Pharmex website is shared for educational purposes only and is not a substitute for professional medical advice or treatment. Always consult a doctor for any health-related questions. Please avoid self diagnosis or delaying medical care based on this content. Our mission is to support informed decisions not replace professional medical guidance.